• Thumbnail for INCOVACC
    INCOVACC (redirect from BBV154)
    iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington...
    7 KB (429 words) - 18:06, 29 November 2023
  • Discovery Solutions Roche Diagnostics Serum Institute of India Vaccines BBV154 Covaxin (Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum...
    337 KB (26,269 words) - 07:29, 20 March 2024
  • Thumbnail for Bharat Biotech
    the novel chimp-adenovirus, a single dose intranasal vaccine (codenamed BBV154) for COVID-19 being developed in collaboration with the American company...
    20 KB (1,339 words) - 01:46, 16 April 2024
  • Thumbnail for List of megaprojects in India
    Biotech/Indian Council of Medical Research Completed iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech...
    179 KB (4,726 words) - 14:56, 18 April 2024
  • Thumbnail for Covaxin
    WHO to suspend procurement of Covaxin through UN agencies in April 2022. BBV154 Case Covaxin (Brazil) COVID-19 vaccination in India Hotez PJ, Bottazzi ME...
    41 KB (3,838 words) - 13:07, 22 March 2024
  • Thumbnail for COVID-19 vaccination in India
    Biotech's intranasal vaccine for COVID-19: Everything we know so far about BBV154". Tech2. Firstpost. 12 March 2021. Prabhu S. "Bharat Biotech's 1st Nasal...
    140 KB (9,633 words) - 22:56, 3 March 2024
  • Military Science. Full (0) Emergency (1) Indonesia iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat Biotech, Precision Virologics...
    318 KB (19,351 words) - 20:33, 14 March 2024
  • Discovery Solutions Roche Diagnostics Serum Institute of India Vaccines BBV154 Covaxin (Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum...
    13 KB (1,241 words) - 00:29, 15 December 2023
  • Thumbnail for COVID-19 vaccine clinical research
    March 2021. "Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19". ClinicalTrials.gov. 12 February 2021. NCT04751682. Archived...
    98 KB (20,593 words) - 02:58, 8 March 2024
  • Discovery Solutions Roche Diagnostics Serum Institute of India Vaccines BBV154 Covaxin (Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum...
    6 KB (371 words) - 05:00, 23 March 2023
  • Discovery Solutions Roche Diagnostics Serum Institute of India Vaccines BBV154 Covaxin (Bharat Biotech) Corbevax (Biological E. Limited) Covishield (Serum...
    7 KB (260 words) - 15:20, 22 April 2023